prof. dr hab. Joanna Mika
Strona główna
/
Instytut
/
Pracownicy
/
prof. dr hab. Joanna Mika
prof. dr hab. Joanna Mika
Dokonania naukowe
- Publikacje
- Granty
Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors
Autorzy: Agnieszka M. Jurga, Ewelina Rojewska, Wioletta Makuch, Joanna Mika
DOI: 10.1080/13880209.2018.1457061
Date: 2018-01-01
Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
Autorzy:
DOI: 10.1016/j.intimp.2017.09.021
Date: 2017-10-12
The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
Autorzy:
DOI: 10.1007/s11481-017-9729-6
Date: 2017-09-01
Transcranial direct current stimulation (tDCS) and its influence on analgesics effectiveness in patients suffering from migraine headache.
Autorzy:
DOI: 10.1016/j.pharep.2017.02.019
Date: 2017-08-01
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.
Autorzy:
DOI: 10.1021/acschemneuro.7b00226
Date: 2017-07-01
Bifunctional opioid/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy.
Autorzy:
DOI: 10.1016/j.ejps.2017.03.029
Date: 2017-06-01
Ból neuropatyczny: etiologia, patomechanizm, implikacje kliniczne wynikające z badań podstawowych
Autorzy:
DOI:
Date: 2017-01-01
Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures.
Autorzy:
DOI: 10.3389/fcimb.2017.00141
Date: 2017-01-01
Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model.
Autorzy:
DOI: 10.3389/fphar.2017.00048
Date: 2017-01-01
Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly® device in prevention of primary headaches.
Autorzy:
DOI: 10.1016/j.pjnns.2017.01.004
Date: 2017-01-01
Grant
OPUS 22 2021/43/B/NZ7/00230 Nowe strategie w farmakoterapii bólu neuropatycznego oparte na modulacji układu chemokin i jego wpływie na rozwój tolerancji opioidowej
15.07.2022 – 14.07.2026